Oncolytic myxoma virus is effective in murine models of triple negative breast cancer despite poor rates of infection.

MT: Regular Issue infectability metastasis oncolytics permissivity triple negative breast cancer virotherapy

Journal

Molecular therapy oncolytics
ISSN: 2372-7705
Titre abrégé: Mol Ther Oncolytics
Pays: United States
ID NLM: 101666776

Informations de publication

Date de publication:
21 Sep 2023
Historique:
medline: 21 9 2023
pubmed: 21 9 2023
entrez: 21 9 2023
Statut: epublish

Résumé

Oncolytic viruses are being heavily investigated as novel methods to treat cancers; however, predicting their therapeutic efficacy remains challenging. The most commonly used predictive tests involve determining the

Identifiants

pubmed: 37732297
doi: 10.1016/j.omto.2023.08.014
pii: S2372-7705(23)00068-2
pmc: PMC10507476
doi:

Types de publication

Journal Article

Langues

eng

Pagination

316-319

Subventions

Organisme : NIGMS NIH HHS
ID : K12 GM088021
Pays : United States

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

E.B. holds intellectual property concerning the use of the vPD1/IL12 virus, as well as additional intellectual property concerning other recombinant oncolytic viruses that is not relevant to the current manuscript.

Références

Sci Immunol. 2017 May 19;2(11):
pubmed: 28763795
Transl Res. 2022 Feb;240:64-86
pubmed: 34757194
NPJ Vaccines. 2022 Oct 19;7(1):120
pubmed: 36261460
PLoS One. 2020 Apr 30;15(4):e0231977
pubmed: 32352982
J Clin Invest. 2019 Mar 4;129(4):1407-1418
pubmed: 30829653
Cancer Res. 2005 Nov 1;65(21):9982-9990
pubmed: 16267023
Mol Cancer. 2014 Apr 13;13:82
pubmed: 24725816
Leuk Res. 2012 May;36(5):619-24
pubmed: 22341701
Exp Hematol. 2013 Dec;41(12):1038-49
pubmed: 24067362
Gene Ther. 2013 Apr;20(4):444-9
pubmed: 22914495
Biomedicines. 2022 Jun 18;10(6):
pubmed: 35740462
J Clin Med. 2020 Jan 08;9(1):
pubmed: 31936317
J Virol. 2018 Mar 14;92(7):
pubmed: 29343569
Int J Oncol. 2011 Mar;38(3):871-8
pubmed: 21249314
Nat Rev Cancer. 2009 Jan;9(1):64-71
pubmed: 19104515
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4640-5
pubmed: 16537421
Melanoma Res. 2008 Apr;18(2):104-11
pubmed: 18337646
Hum Gene Ther. 1999 May 20;10(8):1349-58
pubmed: 10365665
J Immunother Cancer. 2022 May;10(5):
pubmed: 35577502

Auteurs

Raquela J Thomas (RJ)

Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.

Mee Y Bartee (MY)

Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.

Miriam Valenzuela-Cardenas (M)

Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.

Eric Bartee (E)

Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.

Classifications MeSH